Browse Obstetrics/Gynecology Articles by Topic

Update on Treatments for Vulvovaginal Atrophy

Vulvovaginal atrophy, now known as the genitourinary syndrome of menopause (GSM), occurs with the decline of estrogen in the menopausal period. As with many clinical conditions, the spectrum of GSM requires the clinician to consider the effect on the patient’s quality of life. Although many symptoms are pacified effectively with situational lubricants and regular moisturizers, local estrogen is a safe, effective, and affordable way to treat the vulvovaginal changes of menopause.

Infertility Therapy Leads to Increased Risk of Severe Maternal Morbidity

Women undergoing infertility treatment, particularly in vitro fertilization, are at higher risk of severe maternal morbidity, but the overall risk remains low.

Predicting Recurrence After Pelvic Organ Prolapse Surgery

SYNOPSIS: Prediction models can provide helpful information regarding the risk of recurrence after prolapse surgery.

Ultrasound vs. MRI in Diagnosis of Placenta Accreta

The authors of this two-center study found that magnetic resonance is not superior to ultrasound in diagnostic accuracy for placenta accreta spectrum disorders, and its usefulness is tempered particularly by a tendency to falsely upgrade the stage of severity.

State Policymakers Work Toward and Against a Post-Roe Country

Trial Underway for Vaginal Ring Device Designed for HIV Prevention

Researchers are evaluating a vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 in a Phase I study. The trial is being conducted by researchers from the National Institutes of Health-funded Microbicide Trials Network at three U.S. sites in Alabama, California, and Pennsylvania.

FDA Approves New Test for Mycoplasma genitalium

The Food and Drug Administration has approved the first test to help with the diagnosis of Mycoplasma genitalium, a sexually transmitted infection.

Researchers Investigate Microneedle Skin Patch Technology for Contraception Delivery

Researchers are studying microneedle skin patch technology for providing a long-acting contraceptive method that can be self-administered.

Providers Can Improve Teen HPV Vaccination Rates

According to a new study, only about 16% of U.S. adolescents have received the complete vaccination against human papillomavirus (HPV) by the time they turn 13 years of age, despite national recommendations for vaccination at ages 11-12.

Counseling on Contraceptive Use for Patients With Coexisting Medical Conditions

The American College of Obstetricians and Gynecologists has released a practice bulletin to help providers use scientific evidence to guide women with coexisting medical conditions in making the most effective choices.